<?xml version="1.0" encoding="UTF-8"?>
<p>The use of immunotherapy such as tocilizumab, plasma of recovered coronavirus patient and interferons is not discussed in this commentary, as they are currently under study only for critically ill SARS‐COV‐2 patients. No place for these treatments in a patient who is still pregnant should be considered for the time being because, if the pregnant woman presents a very severe form, birth will be considered as a priority.</p>
